Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Grifols, officially known as Grifols, S.A., is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Barcelona, Spain (ES). Founded in 1940, the company has established itself as a global leader in the production of plasma-derived medicines, catering to patients with rare and chronic diseases.
With a strong presence in Europe, North America, and Asia, Grifols focuses on key business areas such as immunology, haematology, and critical care. Its core products, including immunoglobulins and albumin, are distinguished by their high quality and efficacy, setting industry standards. Grifols has achieved notable milestones, including significant advancements in plasma collection and processing technologies, solidifying its market position as a trusted provider of essential healthcare solutions.
+37 vs industry average
Grifols’s score of 79 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Grifols, a Pharmaceutical Preparation Manufacturing company headquartered in Spain, reported total carbon emissions of approximately 1.36 billion kg CO2e in 2025. This figure comprises 121.88 million kg CO2e from Scope 1 emissions, about 83.89 million kg CO2e from Scope 2 (market-based), and approximately 1.15 billion kg CO2e from Scope 3 emissions.
In 2024, Grifols's total emissions were around 1.23 billion kg CO2e, with Scope 1 at 123.22 million kg CO2e, Scope 2 (market-based) at 166.09 million kg CO2e, and Scope 3 at approximately 1.12 billion kg CO2e. For 2023, the company's total emissions were about 1.15 billion kg CO2e, with Scope 1 accounting for 124.76 million kg CO2e, Scope 2 (market-based) for 98.11 million kg CO2e, and Scope 3 for approximately 998.27 million kg CO2e.
Grifols has set ambitious climate commitments, with Science Based Targets initiative (SBTi) validated targets. The company aims to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 42% by 2030, using 2022 as a baseline year. Additionally, Grifols commits to reducing absolute Scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related activities, and upstream transportation and distribution by 25% by 2030, also from a 2022 baseline. Grifols is also working towards achieving net-zero emissions for Scope 1 and 2 by 2050. Furthermore, the company aims to achieve a 55% reduction in GHG emissions per production unit (intensity target) in Scope 1 and Scope 2 by 2030, compared to 2018 levels.
2030
42% reduction in Scope 2
Grifols commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2022 base year.*
2030
42% reduction in Scope 1
Grifols commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2022 base year.*
2030
25% reduction in scope 3 total
Grifols also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related act…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Grifols’s sustainability data and climate commitments
Data year: 2025
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more